These are the most dangerous mushrooms for health that are going to be investigated in Spain: check the complete list

The World Health Organization (WHO) has published a report with the 19 fungus that represent the largest public health threat and the Carlos III Health Institute (ISCIII) will study its presence in the National Health System (SNS), as the Government has informed Europa Press.

In the report of the international organization published last October, the ISCIII was coordinated by Ana Alastruey, a researcher at the National Center for Microbiology (CNM), and it is now the institute, in collaboration with scientific societies and health professionals, who will investigate the presence of these fungi in Spain.

The document ranks the 19 fungi based on their priority and its effects on public health. The fungi ‘Candida auris’, ‘Cryptococus neoformans’, ‘Candida albicans’ and ‘Aspergillus fumigatus’ appear as critical pathogens, causing diseases such as meningitis, pneumonia or blood infections.

• Cryptococcus neoformans

• White ears

• Aspergillus fumigatus

• Candida albicans

• Nakaseomyces glabrata (Candida glabrata)

• Histoplasma spp.

• Eumycetoma causative agents

• mucorales

• Fusarium spp.

• Candida tropicalis

• Candida parapsilosis

• Scedosporium spp.

• Lomentospora prolificans

• Coccidioides spp.

• Pichia kudriavzeveii (Candida krusei)

• Cryptococcus throat

• Talaromyces marneffei

• Pneumocystis jirovecii

• Paracoccidioides spp.

The WHO points out that diseases caused by pathogenic fungi, specifically invasive fungal disease, are growing among groups at special risksuch as immunosuppressed people, transplant recipients, in cancer treatment, with chronic diseases or admitted to intensive care units.

Its study is especially relevant at this time due to the increase in the drug resistance that fight infections caused by fungus. This is complicating the treatment of diseases, aggravated in many cases by problems of access to diagnoses and therapies.

For the WHO this is “particularly worrisome” by the limited list of antifungal drugs available for the treatment of human infections and with few new compounds in research and development.